APTA podcasts connect you with the latest research, important developments in the association, and stories from the physical therapy community. Here's a roundup of four recent episodes worth a listen.
Exploring APTA's "The Economic Value of Physical Therapy in the United States" — Part 1: The Big Picture
"The Economic Value of Physical Therapy in the United States" is a groundbreaking APTA report that, for the first time ever, quantifies physical therapy's potential to deliver true economic value to patients, the U.S. health care system, and society as a whole. In this podcast, two co-chairs from the APTA work group guiding the development of this report join APTA's senior director of brand strategy to talk about how the report was developed, general findings, and how those findings could be leveraged with payers, policymakers, the public, and employers. Listening time — 26:08
PTJ Author Interview: Treadmill Perturbation Training and Fall Prevention in Older Adults
PTJ: Physical Therapy & Rehabilitation Journal Editor-in-Chief Alan Jette interviews Jaap van Dieën about his recently published randomized controlled trial that assessed the gait performance and self-efficacy of 70 older adults at risk of falling after four weeks of treadmill training with or without perturbations. Listening time — 15:10
Defining Moment: Diagnosing a New Beginning
APTA member Steven Brantley, PT, DPT, shares his account of being a nontraditional DPT student and how one professor recognized a hurdle that changed the trajectory of Brantley's schooling — and career. Listening time — 11:16
The Research Agenda for Physical Therapy From the American Physical Therapy Association
Which areas of research are key to advancing the profession? The recently published "Research Agenda for Physical Therapy From the American Physical Therapy Association" responds to that question with a road map that identifies six areas of research priorities that are vital to advancing PT practice. This discussion touches on the evolution of research agendas in physical therapy and what the current agenda says about the maturation of the sciences in the profession. Listening time — 21:34
